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abstract
 
Metabotropic glutamate receptors (mGluRs) control intracellular signaling cascades through activa-
tion of G proteins. The inwardly rectifying K
 
1
 
 channel, GIRK, is activated by the 
 
bg
 
 subunits of G
 
i
 
 proteins and is
widely expressed in the brain. We investigated whether an interaction between mGluRs and GIRK is possible, us-
ing 
 
Xenopus 
 
oocytes expressing mGluRs and a cardiac/brain subunit of GIRK, GIRK1, with or without another
brain subunit, GIRK2. mGluRs known to inhibit adenylyl cyclase (types 2, 3, 4, 6, and 7) activated the GIRK chan-
nel. The strongest response was observed with mGluR2; it was inhibited by pertussis toxin (PTX). This is consis-
tent with the activation of GIRK by G
 
i
 
/G
 
o
 
-coupled receptors. In contrast, mGluR1a and mGluR5 receptors known
to activate phospholipase C, presumably via G proteins of the G
 
q
 
 class, inhibited the channel’s activity. The inhibi-
tion was preceded by an initial weak activation, which was more prominent at higher levels of mGluR1a expres-
sion. The inhibition of GIRK activity by mGluR1a was suppressed by a broad-specificity protein kinase inhibitor,
staurosporine, and by a specific protein kinase C (PKC) inhibitor, bis-indolylmaleimide, but not by PTX, Ca
 
2
 
1
 
 che-
lation, or calphostin C. Thus, mGluR1a inhibits the GIRK channel primarily via a pathway involving activation of a
PTX-insensitive G protein and, eventually, of a subtype of PKC, possibly PKC-
 
m
 
. In contrast, the initial activation of
GIRK1 caused by mGluR1a was suppressed by PTX but not by the protein kinase inhibitors. Thus, this activation
probably results from a promiscuous coupling of mGluR1a to a G
 
i
 
/G
 
o
 
 protein. The observed modulations may be
involved in the mGluRs’ effects on neuronal excitability in the brain. Inhibition of GIRK by phospholipase C–acti-
vating mGluRs bears upon the problem of specificity of G protein (GIRK interaction) helping to explain why re-
ceptors coupled to G
 
q
 
 are inefficient in activating GIRK.
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introduction
 
Glutamate is a major excitatory neurotransmitter in the
brain. It acts on receptors of two major types: (
 
a
 
) iono-
tropic glutamate receptors, which are ligand-gated ion
channels and include the AMPA/kainate and NMDA
receptors, and (
 
b
 
) metabotropic glutamate receptors
(mGluRs)
 
1
 
 that activate G proteins (for reviews see
Hollman and Heinemann, 1994; Nakanishi, 1994; Pin
and Duvoisin, 1995). mGluRs participate in synaptic
plasticity phenomena, playing a role both in long-term
potentiation (LTP) and long-term depression (LTD),
as well as in neurotoxicity and neuroprotection (for re-
views see Bliss and Collingridge, 1993; Bear and Malenka,
1994; Nakanishi, 1994; Pin and Duvoisin, 1995). mGluRs
form a family of eight genes cloned to-date, mGluR1–
mGluR8 (Masu et al., 1991; Houamed et al., 1991;
Tanabe et al., 1992; Abe et al., 1992; Tanabe et al.,
1993; Nakajima et al., 1993; Okamato et al., 1994; Saug-
stad et al., 1994; Duvoisin et al., 1995) that encode pro-
teins with structural similarity but low sequence homol-
ogy to members of the seven-transmembrane domain
receptors superfamily; thus, mGluRs may belong to a
novel superfamily of G protein–coupled receptors (Na-
kanishi, 1994; Gomeza et al., 1996).
mGluRs are subdivided into groups according to
their signal transduction mechanisms, pharmacological
properties, and levels of sequence homology between
the genes. Group I includes mGluR1 (the longest splice
variant is called mGluR1a) and mGluR5, group II in-
cludes mGluR2 and mGluR3, and group III includes
the rest (Nakanishi, 1994; Pin and Duvoisin, 1995).
Group I mGluRs activate phospholipase C (PLC) and
are thus believed to couple to the G
 
q
 
 class of G pro-
teins. When expressed in 
 
Xenopus
 
 oocytes, these recep-
tors activate a large endogenous Ca
 
2
 
1
 
-dependent chlo-
ride current, a fact that enabled molecular cloning by
functional expression of the first mGluR, mGluR1
(Masu et al., 1991; Houamed et al., 1991). Group II
and group III receptors inhibit adenylyl cyclase (AC)
activity, suggesting that they couple to G proteins of the
G
 
i
 
/G
 
o
 
 class (Gilman, 1987).
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Positive and Negative Coupling of mGluRs to GIRK
 
The molecular mechanisms by which mGluRs exert
their physiological effects are not yet fully understood.
Their known effects include direct mediation of gluta-
matergic synaptic transmission at some synapses, both
hyperpolarizing and depolarizing. Presynaptic group II
and III autoreceptors inhibit transmitter release. All three
groups have been shown to inhibit L-type voltage-gated
Ca
 
2
 
1
 
 channels, and groups I and II also inhibit N-type
channels. mGluRs also modulate the ionotropic AMPA,
NMDA, and GABA-A receptors (reviewed by Nakanishi,
1994; Pin and Duvoisin, 1995). mGluRs inhibit several
types of K
 
1
 
 currents: the voltage-dependent M-type cur-
rent, the Ca
 
2
 
1
 
-activated current (IK
 
AHP
 
), a voltage-depen-
dent K
 
1
 
 current I
 
K,slow
 
, and resting K
 
1
 
 currents (Schwartz,
1993; Guerineau et al., 1994; Ikeda et al., 1995; Luthi et
al., 1996). Activation of K
 
1
 
 currents by mGluRs has been
shown in cerebellar granule cells (Fagni et al., 1991).
GIRK1 (KGA, Kir3.1; Kubo et al., 1993; Dascal et al.,
1993
 
b
 
) is a member of the GIRK, or Kir 3, family of G
protein–activated inward rectifying K
 
1
 
 channels (re-
viewed by Doupnik et al., 1995), which also includes
GIRK2 and GIRK3 cloned from brain (Lesage et al.,
1994; Duprat et al., 1995), GIRK4 (CIR) from atrium
(Krapivinsky et al., 1995
 
a
 
; Lesage et al., 1995), and
GIRK5 (XIR) present in 
 
Xenopus
 
 oocytes (Hedin et al.,
1996). Functional inward rectifier channels are be-
lieved to be heterooligimers formed by GIRK1 with the
other subunits (Lesage et al., 1995; Kofuji et al., 1995;
Krapivinsky et al., 1995
 
a
 
; Hedin et al., 1996). In the
heart, acetylcholine (ACh) released from the vagus
nerve binds to the muscarinic type 2 receptor (m2R)
and activates the GIRK channel, mediating the para-
sympathetic negative chronotropic effect. Similar chan-
nels, most probably of the GIRK family, are activated in
the brain by serotonin via 5HT1A receptors, GABA via
GABA
 
B
 
 receptors, opioids, etc., and presumably partici-
pate in regulation of neuronal excitability (for review,
see North, 1989; Hille, 1992
 
a
 
,
 
b
 
; Wickman and Clap-
ham, 1995). The channel is activated via a membrane-
delimited pathway, by direct binding of the 
 
bg
 
 subunits
released from heterotrimeric G proteins containing
pertussis toxin (PTX)-sensitive G
 
a
 
 subunits (G
 
i
 
/G
 
o
 
 fam-
ily; Breitwieser and Szabo, 1985; Pfaffinger et al., 1985;
Logothetis et al., 1987; Ito et al., 1992; Huang et al.,
1995; Inabobe et al., 1995; Krapivinsky et al., 1995
 
b
 
;
Kunkel and Peralta, 1995).
The fact that GIRK is activated by receptors coupled
to G
 
i
 
/G
 
o
 
 proteins makes it feasible that the G
 
i
 
-coupled
mGluRs are capable of activating the channel. Such ac-
tivation may be relevant to brain function. Extensive
expression of GIRK1 and GIRK2 RNA and protein in
the brain was revealed by in situ hybridization and im-
munohistochemical methods (Karschin et al., 1994,
1996; Bausch et al., 1995; Ponce et al., 1996). mGluR
expression in the brain is wide, varying from receptor
to receptor (see Nakanishi, 1994; Pin and Duvoisin,
1995), and there are areas in which expression of
mGluRs and GIRK1 overlaps.
Our study shows that, indeed, the G
 
i
 
-coupled mGluRs
(types 2, 3, 4, 6, and 7) activate the GIRK channel when
coexpressed in 
 
Xenopus 
 
oocytes. In addition, a negative
coupling exists between the PLC-coupled mGluRs (types
1 and 5) and GIRK, most probably mediated by activation
of the G
 
q
 
–phospholipase C pathway and a PKC subtype.
 
materials and methods
 
Preparation of RNAs and Oocytes
 
DNA plasmids containing the various clones were linearized with
the appropriate restriction enzymes using a standard protocol
(Dascal and Lotan, 1992): GIRK1 (Dascal et al., 1993
 
b
 
) with
XhoI, mGluR3 and mGluR4 (Tanabe et al., 1992) with HindIII,
the other mGluRs (Masu et al., 1991; Tanabe et al., 1992; Abe et
al., 1992; Nakajima et al., 1993; Okamoto et al., 1994) with NotI.
G
 
b
 
1
 
 (Fong et al., 1986) and G
 
g
 
2
 
 (Gautam et al., 1989) were sub-
cloned into the EcoRI site of pGEMHE vector (Liman et al.,
1992) and linearized with NheI. cDNA for GIRK2 was prepared
as described (Kofuji et al., 1995). The linearized plasmids were
transcribed in vitro by SP6 (mGluR1a), T3 (mGluR2 and
mGluR4) or T7 (the other clones) by RNA polymerase using
standard procedures (Dascal and Lotan, 1992). The cDNAs were
kindly provided by Drs. S. Nakanishi (all mGluRs, Kyoto Univer-
sity, Japan), E. Peralta (m2R, Harvard University, Cambridge,
MA), P. Kofuji (GIRK2, Caltech, Pasadena, CA), M. Simon (G
protein subunits, Caltech, Pasadena, CA), E. Liman (pGEMHE,
Harvard University, Boston, MA).
Oocytes were isolated, incubated, and injected with RNA as de-
scribed (Dascal and Lotan, 1992). The incubation solution,
NDE96, contained 96 mM NaCl, 2 mM KCl, 1 mM MgCl
 
2
 
, 1 mM
CaCl
 
2
 
, 5 mM HEPES (pH 
 
5
 
 7.5), 2.5 mM Na
 
1
 
-pyruvate, and 50
 
m
 
g/ml gentamycin. The amounts of RNA injected per oocyte
were as follows: GIRK1 and GIRK2, 0.2–1 ng; mGluR1a, 25–5,000
pg; mGluR2, 1–2 ng; mGluR3, 0.4–5 ng; mGluR4, 40 ng;
mGluR5, 5 ng; mGluR6, 2–5 ng; mGluR7, 40 ng; G
 
b
 
1
 
, 1 ng; G
 
g
 
2
 
,
1 ng; m2R, 100 pg. Electrophysiological experiments were per-
formed 3–7 d after RNA injection.
 
Electrophysiological Measurements
 
For two-electrode whole-cell experiments oocytes were voltage-
clamped at 
 
2
 
80 mV using OC-725B oocyte clamp (Warner Instru-
ments, Hamden, CT). Agarose cushion electrodes (Schreibmayer
et al., 1994) were used to ensure stable long-lasting recording.
Data acquisition and analysis were performed with pCLAMP soft-
ware (Axon Instruments, Foster City, CA). The oocyte was trans-
ferred from the incubation solution, NDE96, to the recording
chamber, containing ND96 solution (identical to NDE96 besides
not containing pyruvate and gentamycin). The responses to neu-
rotransmitters were recorded in a high K
 
1
 
 solution (hK, identical
to ND96 except for NaCl and KCl concentrations, which are re-
versed; Dascal et al., 1993
 
a
 
). Glutamate (100 
 
m
 
M, or for mGluR7
experiments, 1 mM) was added to this solution, and in some ex-
periments Ba
 
2
 
1
 
 followed, to block GIRK (Dascal et al., 1993a). A
 
z
 
90–95% block of GIRK was produced by 300 (GIRK1/GIRK5)
or 1,000 (GIRK1/GIRK2) 
 
m
 
M Ba
 
2
 
1
 
. Current-voltage curves were
obtained at various stages by applying a voltage ramp, from 
 
2
 
120
mV to 
 
1
 
50 mV during 0.5–1 s, and subtracting the voltage ramp 
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performed in Ba
 
2
 
1
 
-containing hK. Ba
 
2
 
1
 
 does not significantly
block the endogenous (“native”) oocyte’s K
 
1
 
 currents at these
concentrations (Dascal et al., 1993
 
a
 
). These curves, therefore,
represent exclusively GIRK activity at the specified time.
In patch-clamp experiments, single channel currents (at 
 
2
 
80
mV) were filtered at 2 kHz, sampled at 4 kHz with the Axotape
software (Axon Instruments), and analyzed using the pCLAMP
software. Pipette solution contained: 144 mM KCl, 2 mM NaCl,
1 mM MgCl
 
2
 
, 1 mM CaCl
 
2
 
, 0.1–1 mM GdCl
 
3
 
, 10 mM HEPES/
KOH, pH 7.5. Bath (500 
 
m
 
l) solution contained: 140 mM KCl, 6
mM NaCl, 4 mM MgCl
 
2
 
, 1 mM EGTA, 10 mM HEPES/KOH, pH
7.5. For calculating the open probability of a single channel, an
idealized record was divided into 5-s bins, and then P
 
o
 
 was aver-
aged over the desired time periods (e.g. 3-min stretches as in Fig.
4). The number of channels in a patch was estimated from the
maximal number of overlapping openings, and records with more
than four channels were excluded from the study.
 
Treatment of Oocytes with EGTA, PTX, and with
PKC Blockers
 
Oocytes were injected with 20 nl of 50 mM K
 
1
 
-EGTA (pH 
 
5
 
 7.6)
2–8 h before the experiment; this corresponds to 
 
z
 
1 mM EGTA
in the oocyte. The A-protomer of PTX (List Biological Laborato-
ries, product #182; kindly provided by Dr. M. Cohen-Armon, Tel
Aviv University) was dissolved in sterile water at 20 ng/
 
m
 
l accord-
ing to manufacturer’s instructions; intermediate concentrations
were made by further dilution in water to 0.18–7 ng/
 
m
 
l (depend-
ing on the batch of PTX), and 30 nl were injected into oocytes
10–20 h before the recording session. The activity of PTX was
tested independently for its ability to cause a 
 
z
 
70–90% block of
the response to acetylcholine in oocytes injected with GIRK1,
GIRK2, and m2R (data not shown).
Staurosporine and calphostin C (Sigma Chemical Co., St.
Louis, MO) were dissolved in DMSO at 3 mM and stored in 2–3
 
m
 
l aliquots at 
 
2
 
20
 
8
 
C. 1 
 
m
 
l of the stock solution of staurosporine
or calphostin C was added to 1 ml of the standard NDE96 me-
dium in which the oocytes were incubated (the solutions were ex-
posed to light) for at least 2 h before electrophysiological record-
ing. Control (untreated) oocytes were incubated in 0.1% solu-
tion of DMSO in NDE96. In one experiment, 20 nl of 30 or 300
 
m
 
M calphostin C were injected into the oocytes 2–6 h before re-
cording the currents. Bis-indolylmaleimide (BIS; Calbiochem
Corp., La Jolla, CA) was dissolved in water at 5 mM and stored in
aliquots at 
 
2
 
20
 
8
 
C. Oocytes were injected with 30 nl of a water so-
lution of BIS at 150 
 
m
 
M (this corresponds to 
 
z
 
5 
 
m
 
M BIS in the
oocyte) and, in addition, incubated in 5 
 
m
 
M BIS 2–4 h before re-
cording. Since BIS was usually tested in the same experiments as
staurosporine, the incubation solution also contained 0.1%
DMSO. The recording was performed in solutions free of block-
ers, no later than 5 min after the removal of the oocytes from the
blocker-containing incubation medium. Although staurosporine
has been reported to block directly the G protein-activated K
 
1
 
channel (Lo and Breitwieser, 1994), this effect occurs at higher
concentrations (
 
.
 
10 
 
m
 
M) than used by us (3 
 
m
 
M) and is
promptly reversed upon the washout of the drug.
4
 
b
 
-phorbol-12-myristate 13-acetate (PMA; Sigma Chemical
Co.) was dissolved in DMSO at 100 
 
m
 
M and stored in aliquots at
 
2
 
20
 
8
 
C. All solutions containing PMA were protected from light.
 
Statistics and Presentation of Data
 
The results in the text and in the figures are presented as mean
 
6
 
 SEM, 
 
n
 
 
 
5
 
 number of cells tested. Comparisons between two
groups were done using two-tailed Student’s 
 
t test. Comparisons
between more than two groups were done using one-way non-
parametric ANOVA followed by Dunn’s test, using the SigmaStat
software (Jandel Scientific, Corte Madera, CA).
results
G i/Go-coupled mGluRs Activate GIRK via PTX-sensitive
G Proteins
The GIRK channels were expressed by injecting RNA
of GIRK1 alone or with RNA of GIRK2. In oocytes in-
jected with GIRK1 RNA alone, the channels are most
probably formed by GIRK1 and the endogenous sub-
unit, GIRK5 (Hedin et al., 1996), and they will be
termed GIRK1/GIRK5 channels. In oocytes injected
with RNAs of GIRK1 and GIRK2 (a combination espe-
cially relevant to GIRK composition in the brain), the
amplitude of GIRK currents was increased five- to ten-
fold as compared with the injection of GIRK1 RNA
alone; therefore, a majority of channels probably repre-
sented GIRK1/GIRK2 heterooligomers (cf. Kofuji et
al., 1995).
Coinjection of GIRK1 or GIRK11GIRK2 RNAs with
mGluR2 RNA into Xenopus oocytes gave rise to a
glutamate-activated inwardly rectifying K1 current,
which was not present in oocytes injected with the
channel RNA alone, or in uninjected oocytes. Fig. 1 A
depicts a typical two electrode voltage-clamp experi-
ment with an oocyte coexpressing mGluR2 and GIRK1.
Since the channel is an inward rectifier, the bathing so-
lution is first changed from the standard incubation
medium, ND96, to a high K1 solution, hK (containing
96 mM K1), permitting an inward K1 current at a hold-
ing potential of 280 mV. Application of glutamate in
the hK solution induced a large increase in the current,
designated Iglu. The GIRK current was blocked by 300–
1,000 mM Ba21, leaving mainly a K1 current endoge-
nous to the oocyte, denoted In and ranging between 50
and 300 nA (Dascal et al., 1993a, b). The current in hK
alone consists of both In and the basal GIRK activity,
designated IhK, and the application of Ba21 enables to
distinguish between them. Unless stated otherwise, In
(revealed following Ba21 block of GIRK in each cell)
was always subtracted from the total current; thus, all
reported values pertain to net GIRK currents. In oo-
cytes injected with GIRK1, IhK was usually between 100
and 600 nA, and Iglu between 0.4 and 1.5 mA (depend-
ing on the oocyte batch, amount of injected RNA, and
incubation time). In oocytes injected with GIRK1 and
GIRK2 (200-500 pg RNA/oocyte), IhK was usually be-
tween 0.8 and 5 mA, and Iglu was between 2 and 10 mA.
Fig. 1 B shows the net GIRK1/GIRK5 current-voltage
relationship before and after application of glutamate
and demonstrates the inward rectification of the cur-
rent induced by glutamate. The glutamate dose-response
curve showed an EC50 of 0.63 mM in oocytes injected480 Positive and Negative Coupling of mGluRs to GIRK
with mGluR2 and GIRK1 (Fig. 1 C). This is somewhat
lower than the 4 mM value reported by Tanabe et al.
(1992) in fibroblasts expressing mGluR2, and may re-
flect the existence of spare receptors in the oocytes un-
der the conditions utilized here.
The channel activated by 10–100 mM glutamate in
oocytes expressing GIRK1 and mGluR2 displayed the ex-
pected characteristics (Dascal et al., 1993b; Kubo et al.,
1993) in cell-attached patches: inward rectification (note
that openings were observed at 280 but not at 180 mV;
Fig. 1 D), current of 2.65 6 0.05 pA at 280 mV with 154
mM K1 in the pipette (n 5 6), and a slope conductance
of 37 6 1.5 pS (n 5 3) between 280 and 220 mV.
GIRK currents activated by glutamate via mGluR2
were strongly blocked by the injection of the catalytic
subunit (A-protomer) of PTX (we found this treatment
much more efficient than a 16–24 h incubation of the
cells in heteromeric PTX; data not shown). In oocyte
from two donors injected with RNAs of GIRK1, GIRK2,
and mGluR2, PTX treatment reduced IhK by 55.1 6
7.2% (n 5 9, P , 0.01), and Iglu by 71.4 6 4.7% (n 5 8,
P , 0.01). The inhibition of IhK by PTX suggests that at
least a part of the basal activity of GIRK is due to activa-
tion by Gbg released due to a basally occurring GTPase
cycle of PTX-sensitive G proteins (see Okabe et al.,
1991). The same PTX treatment did not affect a volt-
age-dependent Shaker H4 current (data not shown) or
the Ca21-activated Cl2 current evoked by glutamate via
mGluR1a (see below).
In oocytes injected with GIRK1 RNA, the GIRK cur-
rent evoked by activating mGluR3 and mGluR6 was
smaller than the mGluR2-activated current, ranging
from  ,100 to 200–300 nA for the same RNA amounts.
Visible activation of GIRK1/GIRK5 by mGluR4 and
mGluR7 required tenfold higher RNA amounts, and
the current was in the range of 50–70 nA. The fact that
different Gi/Go-coupled mGluRs gave different re-
sponse amplitudes to agonist could be due either to dif-
ferent levels of protein expression, or to different levels
of activation of the appropriate G proteins.
Figure 1. GIRK activation by
mGluR2. (A) Two-electrode volt-
age-clamp recording from a cell
expressing mGluR2 and GIRK1.
Bars above trace show solutions
applied. (B) Current-voltage rela-
tionships of the GIRK currents at
the times indicated by arrows
in A: in hK alone (1) and in
glutamate (2). Each net GIRK1
I-V curve was obtained by sub-
traction of the I-V curve recorded
after addition of Ba21. (C) Gluta-
mate dose-response curve, with
apparent  Kd  5 0.63 mM, fitted to
the standard Michaelis-Menten
equation. n 5 3 or 4 cells for
each glutamate concentration.
(D) A cell-attached patch clamp
record of the activity of the GIRK
channel with 10 mM K-glutamate
in the pipette, from an oocyte in-
jected with RNAs of GIRK1 and
mGluR2.481 Sharon et al.
Gq-coupled mGluRs Inhibit GIRK1 via a Pathway Involving 
a PTX-insensitive G Protein
Oocytes coinjected with RNAs of GIRK1 (or GIRK1 and
GIRK2) and the PLC-coupled mGluR1a or mGluR5
were exposed to glutamate in the hK solution. This
caused a large transient Cl2 current (Fig. 2 A), as de-
scribed previously for oocytes injected with mGluR1a
or mGluR5 alone (Masu et al., 1991; Abe et al., 1992).
In line with previous reports (Houamed et al., 1991;
Masu et al., 1991), the mGluR1a-activated Ca21-depen-
dent Cl2 current was not suppressed by the PTX treat-
ment: it was 1,700 6 530 nA in control and 2,050 6 725
nA in PTX-treated oocytes (n 5 4 in each group, oo-
cytes of one donor; P . 0.7). This is consistent with ac-
tivation of the PLC cascade via Gq/11 (Simon et al.,
1991; Birnbaumer, 1992) followed by a rise in [Ca21]in
and activation of the Ca21-dependent Cl2 current en-
dogenous to the oocyte (reviewed by Dascal, 1987).
After the large Cl2 current transient subsided, the re-
sidual current was smaller than the initial current in hK
Figure 2. Inhibition of GIRK
by mGluR1a. (A) Two-electrode
voltage-clamp recording from a
single cell injected with RNAs of
GIRK1 (500 pg) and mGluR1a
(25 pg). ND, stands for ND96.
(B) Average recording from
cells of one donor exposed to
glutamate (d, n 5 4) and unex-
posed to glutamate (s, n 5 6).
Ba21 was not applied, and cur-
rent was expressed as percent of
the current in hK solution (IhK 1
In); I 5 0 in ND96. (C) Inhibition
of GIRK channel activity by
mGluR1a in EGTA-treated oo-
cytes: comparison of cells ex-
posed to glutamate (n 5 4) to
cells unexposed to glutamate
(n  5 4). The cells were from the
same donor, injected with 25 pg
mGluR1a RNA and 500 pg
GIRK1 RNA. The ND96 solution
was changed to the hK solution
at time t 5 0. Currents in each
oocyte were normalized to the
peak basal GIRK current, IhK. Av-
erage traces from all 4 oocytes
are shown. The mean IhK was
313  6 29 nA (n 5 8) in these oo-
cytes. (D) Current-voltage rela-
tionships of GIRK currents at the
times indicated by arrows in C, in
a cell injected with EGTA: in hK
(1) and in glutamate after the
decay of the current (2). Net
GIRK I-V curves were obtained as
in Fig. 1 B. (E) Inhibition of
GIRK1/GIRK2 channel activity
by mGluR1a in EGTA-treated oo-
cytes. Presentation as in C; n 5 4 oocytes for each treatment. In this batch, oocytes were injected with 50 pg mGluR1a RNA and 250 pg of
each of the GIRK1 and GIRK2 RNAs. Average IhK was 4,126 6 707 nA (n 5 8). (F) Absence of glutamate-activated inward current in oo-
cytes incubated in 300 mM BaCl2. Oocytes were injected with RNAs of mGluR1a (25 pg) and GIRK1 (500 pg) and treated with EGTA. Ba21
(300 mM) was added to all solutions. Currents in each cell were normalized to the peak inward current observed in the hK solution, which,
because of the block of GIRK, equals to In (the average current in the hK solution was 86 6 8 nA, n 5 5). (G) Inhibition of m2R-induced
activation of GIRK by mGluR1a. Oocytes expressing mGluR1a, m2R, and GIRK1, and injected with EGTA before recording, were placed in
hK solution and then exposed to 10 mM ACh, which activated GIRK (the record starts at the time of addition of ACh). This current is de-
noted IACh. 3 min after exposure to ACh (at the time indicated by the arrow), one group of cells was exposed to glutamate (d, n 5 3),
which caused a decrease in the current compared with cells that were not exposed to glutamate (s, n 5 3). The current is expressed as
percent of IACh; records averaged from all oocytes in each group are shown.482 Positive and Negative Coupling of mGluRs to GIRK
(see Fig. 2 A), a decline that was not seen in oocytes in-
jected with mGluR1a or mGluR5 alone (data not shown).
This suggests that activation of these receptors inhibits
the GIRK channel activity. The GIRK-related portion of
the total current is shown in detail in Fig. 2 B, which il-
lustrates a recording in an experiment similar to that
shown in Fig. 2 A, averaged from several cells from one
donor expressing mGluR1a and GIRK1. Glutamate
caused a pronounced inhibition of the GIRK current
(d). Since it has been previously shown that oocytes ex-
pressing GIRK1 show a slow spontaneous desensitiza-
tion of IhK (Kovoor et al., 1995), we have recorded IhK
without applying glutamate; cells unexposed to gluta-
mate showed only a mild desensitization of the current
(s). We estimated that IhK was inhibited by 30–60%; a
more accurate estimate was difficult because of the ex-
istence of a small residual Cl2 current in cells exposed
to glutamate.
To observe the inhibition of GIRK by mGluR1a with-
out the interference of the Ca21-dependent Cl2 cur-
rent, we injected the calcium chelator, EGTA, into the
oocytes before the recording (in these experiments,
the oocytes were injected with 25–50 pg mGluR1a RNA
and 500 pg GIRK1 RNA). This treatment abolished all
of the transient and most of the sustained Ca21-acti-
vated Cl2 current (Boton et al., 1989) and allowed the
holding current to return, after washout of glutamate
and hK, close to its original value in the ND96 solution.
As shown in Fig. 2 C, IhK decreased to less than half of
its peak value three minutes after the application of
glutamate (trace denoted: 1 glutamate). In the same
oocyte batch as the above, in cells unexposed to
glutamate IhK decreased by ,15% after the same pe-
riod of time in the hK solution (Fig. 2 C, no glutamate).
Averaging over several oocyte batches showed that in
cells exposed to glutamate the GIRK1/GIRK5 current
was reduced to 43.9 6 2.4% of the initial IhK (n 5 21,
from 5 donors), whereas in unexposed cells it de-
creased only to 81.9 6 3.2% (n 5 6, from 2 donors).
Thus, the net inhibition of the GIRK current caused by
glutamate via activation of mGluR1a was about 46%.
Fig. 2 D shows the net GIRK current-voltage relation-
ship before and after the application of glutamate and
confirms that the current inhibited by glutamate is an
inward rectifier. Similarly, activation of mGluR1a inhib-
ited the GIRK1/GIRK2 current (Fig. 2 E) by 57.9 6
3.9% 5 min after glutamate application (oocytes from 2
donors; see Fig. 5 D for details).
To investigate whether the transient inward current
appearing at the onset of exposure to glutamate in oo-
cytes treated with EGTA (Fig. 2, C and E; compare with
Fig. 2 A) is an activation of GIRK1 or a small residual
Cl2 current owing to incomplete chelation of intracel-
lular Ca21, cells expressing GIRK1 were perfused with
Ba21-containing hK. In this solution the GIRK channel
(presumably GIRK1/GIRK5) is blocked by Ba21 and
cannot be activated, whereas the native Ca21-activated
Cl2 current is not blocked by Ba21 (Singer-Lahat et al.,
1994). In cells given this treatment no inward current
was evoked by glutamate (Fig. 2 F). Cells from the same
donor but unexposed to Ba21 showed the usual gluta-
mate-activated inward current followed by inhibition
(n  5 4; data not shown). With 25 pg mGluR1 RNA/oo-
cyte, the average glutamate-evoked GIRK1/GIRK5 cur-
rent in oocytes treated with EGTA was 28.9 6 16.3% of
IhK (n 5 16, from 5 donors. IhK in these cells was 346 6
41 nA). The current-voltage relationships of the initial
inward current evoked by glutamate in these oocytes
showed clear inward rectification and a reversal poten-
tial of z0 mV (data not shown) and thus could not rep-
resent the Ca21-activated Cl2 current, which shows out-
ward rectification and reverses at z220 mV (Miledi
and Parker, 1984). These results suggest that the gluta-
mate-induced inward current in EGTA-treated cells ex-
pressing mGluR1a and GIRK1 is due to activation of
the GIRK channel. Similar results were obtained with
GIRK1/GIRK2 channels in EGTA-injected oocytes
(e.g., Fig. 2 E and data not shown). With 50 pg
mGluR1a RNA/oocyte, the mGluR1a-activated GIRK1/
GIRK2 current was 664 6 121 nA (24 6 6% of IhK, n 5
7, oocytes from two donors).
It is possible to activate GIRK by ACh in oocytes ex-
pressing the muscarinic m2 receptor, m2R. We tested
whether mGluR1a is able to inhibit the m2R-induced
GIRK current in oocytes expressing mGluR1a, m2R
and GIRK, and treated with EGTA (Fig. 2 G). ACh
caused the expected agonist-induced activation of the
channel, while applying glutamate 3 min later caused a
decrease of this current (d) which was clearly larger
than the desensitization in cells exposed only to ACh
(s). The fact that application of glutamate did not
evoke an additional inward current strengthens the
conclusion reached above, that in oocytes expressing
mGluR1a and GIRK1 and injected with EGTA, gluta-
mate does not induce a Ca21-activated Cl2 current. In
this experiment GIRK was not activated in response to
glutamate, presumably because it was already activated
by ACh.
PTX was used to examine which G proteins are in-
volved in activation and inhibition of GIRK by mGluR1a
(Fig. 3). In oocytes of one donor expressing GIRK1,
GIRK 2, and mGluR1a (50 pg receptor RNA/oocyte)
and injected with EGTA, glutamate evoked an inward
GIRK current, Iglu, of 775 6 110 nA (n 5 4), and the in-
hibition of IhK was z70% 5 min after application of
glutamate (not shown). In PTX-treated oocytes of the
same donor, the inward GIRK current was reduced to
32 6 10 nA (a 96% reduction), whereas the inhibition
was somewhat weaker than in untreated cells but still
significant, z47% (Fig. 3 A). Fig. 3, B and C, summa-483 Sharon et al.
rizes the effects of PTX treatment in oocytes of two do-
nors and confirm that the PTX almost completely
(89%) suppressed the mGluR1a-evoked GIRK activa-
tion. IhK was reduced by z40% (Fig. 3 B), whereas the
mGluR1a-induced inhibition was reduced from 57 to
42%, i.e. by z26% (Fig. 3 C).
Involvement of a Diffusible Second Messenger and of Protein 
Kinase C in mGluR1a-induced Inhibition of GIRK
Cell-attached patch-clamp experiments were exploited
to examine whether the inhibition of GIRK channels by
mGluR1a involves the production of a diffusible second
messenger. Oocytes were injected with RNAs of mGluR1a
and GIRK1, as well as of Gb1 and Gg2 subunits of het-
erotrimeric G proteins (to increase the basal GIRK1 ac-
tivity; Reuveny et al., 1994). In Fig. 4 A, the upper panel
shows the persistent activity of the channel in the ab-
sence of agonist. The lower panel demonstrates the re-
duction in this activity following application of gluta-
mate, though this inhibition was delayed. Glutamate
was applied outside the pipette in the cell-attached con-
figuration, so its effect on the channel sealed in the pi-
pette is likely to be mediated by a second messenger
(Hille, 1992a). Fig. 4 B shows the average open proba-
bility, Po, for cells exposed to glutamate, in comparison
to unexposed cells. The inhibition of GIRK1 took roughly
three minutes to develop, and was z50%. The decrease
in Po appeared transient, but this has not been system-
atically studied.
Since mGluR1a activates PLC, which leads to activa-
tion of PKC, and since the PKC activator, PMA, has
been reported to inhibit GIRK current in the oocytes
(Chen and Yu, 1994), we tested whether protein phos-
phorylation is involved in the inhibition of GIRK by
mGluR1a, by using a series of protein kinase inhibitors:
a broad-specificity protein kinase inhibitor staurospo-
rine acting at the protein kinase catalytic site, a specific
PKC inhibitor bis-indolylmaleimide (BIS) acting at the
PKC catalytic site, and a specific PKC inhibitor calphos-
tin C acting at the diacylglycerol binding site (Hidaka
and Kobayashi, 1992). Oocytes expressing mGluR1a
and GIRK1/GIRK2 channels were incubated for 2–4 h
in medium containing 3 mM staurosporine or 5 mM
BIS; in addition, BIS was also injected into the oocytes
(see materials and methods). Fig. 5 A shows that nei-
ther staurosporine nor BIS significantly altered the
basal activity of GIRK. However, both blockers some-
what reduced the rate of the spontaneous decay (basal
desensitization) of IhK (Fig. 5 B), suggesting that basal
activity of PKC could account for part of the basal GIRK
desensitization.
Fig. 5 C shows an example of the effect of staurospo-
rine on the glutamate response in a representative oo-
cyte expressing mGluR1a, GIRK1, and GIRK2, and Fig.
5, D and E, provides a summary of experiments with
BIS and staurosporine in oocytes of two donors. Both
staurosporine and BIS almost fully suppressed gluta-
mate-induced inhibition of the GIRK current (Fig. 5 D)
and slightly enhanced the initial GIRK activation (Fig.
5 E). Similarly, with GIRK1/GIRK5 channels staurospo-
rine almost completely suppressed the inhibition but
did not significantly alter the activation phase (n 5 3,
one oocyte batch; data not shown). Similar results were
obtained with mGluR5 (data not shown). However, nei-
ther a 4-h incubation with calphostin C nor injection of
Figure 3. PTX suppresses
mGluR1a-induced activation
of GIRK but has little effect on
mGluR1a-induced GIRK inhibi-
tion. (A) Inhibition of GIRK1/
GIRK2 channel activity by
mGluR1a in EGTA-injected oo-
cytes treated with PTX: com-
parison of cells exposed to
glutamate (n 5 4) to cells un-
exposed to glutamate (n 5 4).
The cells were injected with
RNAs of mGluR1a (50 pg),
GIRK1 (250 pg), and GIRK2
(250 pg). The ND96 solution was changed to the hK solution at time t 5 0. Currents in each oocyte were normalized to the peak basal
GIRK current, IhK. Records averaged from all oocytes in each group (n 5 4) are shown. Average IhK was 833 6 193 nA (n 5 8) in these oo-
cytes, and 1,993 6 331 nA (n 5 8) in PTX-untreated oocytes of the same donor. (B) The effect of PTX treatment on basal (IhK) and
glutamate-evoked (Iglu) GIRK1/GIRK2 currents: a summary from oocytes of two donors (n 5 8 in each group). IhK or Iglu in each cell was
expressed as percent of control (i.e., average IhK or Iglu in the untreated group of oocytes of the same donor), and the results were averaged
across all cells. Asterisks denote statistically significant differences, P , 0.05 or better. (C) The effect of PTX treatment on mGluR1a-
induced GIRK1/GIRK2 inhibition. Same two oocyte batches as in B. The extent of glutamate-evoked inhibition was calculated as follows:
first, in each cell, the current at the end of the record (t 5 8 min in the hK solution) was expressed as percent of IhK measured at t 5 2 min.
In glutamate-exposed oocytes, this value was normalized to the average current in cells unexposed to glutamate at t 5 8 min. This normal-
ization procedure allowed averaging of the results despite the large difference in the absolute amplitudes of the currents recorded in
oocytes of different donors.484 Positive and Negative Coupling of mGluRs to GIRK
this blocker into the oocytes suppressed glutamate-
induced inhibition of GIRK1/GIRK5 channels: the cur-
rent was reduced to 35.3 6 7.5% of the initial IhK (n 5
7, from 2 donors), similar to the 43.9% observed in oo-
cytes untreated with PKC blockers.
In view of the existing controversy concerning the in-
hibitory effect of phorbol esters on GIRK (cf. Kovoor et
al., 1995 vs. Chen and Yu, 1994), we examined the ef-
fect of the phorbol ester, PMA, on the basal activity of
the GIRK1/GIRK2 channels. Fig. 5 F demonstrates a
clear suppression of the GIRK currents by 10 nM PMA.
Similar results were obtained with GIRK1/GIRK5 chan-
nels (G. Levin, D. Vorobiov, and N. Dascal, unpub-
lished results). Thus, it appears that the inhibition of
GIRK channels caused by the activation mGluR1a is
mediated by a subtype of PKC.
Since the glutamate-induced activation in EGTA-
treated oocytes expressing mGluR1a and GIRK1 is tran-
sient, even when the inhibition is abolished by stauro-
sporine (see Fig. 5), we tested whether the inhibition of
the basal GIRK current by glutamate is also transient.
After reaching peak inhibition, all cells tested slowly be-
gan to show recovery of IhK. In the constant presence of
glutamate, 10 min after peak inhibition, 68.7 6 21.4%
(n 5 7, from 3 donors) of the inhibited current had re-
covered. After washout of glutamate and hK the hold-
ing current did not return to its baseline value, suggest-
ing that at least some of the inward current that devel-
oped during recovery might be a chloride current or
an enlarged leak current. If the total deflection of the
holding current is considered to be a part of the appar-
ent recovery (and is thus subtracted from the recovered
current), a recovery of 49.4 6 22.1% is exhibited 10
min after peak inhibition in the same cells. These data
suggest that not only activation but also inhibition of
GIRK by mGluR1 are transient. One possibility is that
mGluR1a and mGluR5 are desensitized shortly after be-
ing activated. The inhibition, however, diminishes at a
slower rate than the activation. This is in accord with
the activation being mediated by a fast membrane-
delimited pathway and the inhibition being mediated
by a slow process that involves phosphorylation, while
dephosphorylation is probably required for recovery.
Effects of High mGluR1a RNA Concentrations
When 100 to 200-fold more RNA was injected into oo-
cytes (5 ng per oocyte, instead of 25–50 pg in the inhi-
bition experiments), two interesting results were ob-
tained. The first is that in EGTA-treated cells, applica-
tion of glutamate in the hK solution caused a large
activation of GIRK1/GIRK5 channels, around 1 mA in
amplitude (data not shown). This activation was not a
Cl2 current, as witnessed by the inward-rectifying cur-
Figure 4. Glutamate applied
outside the patch pipette
blocks GIRK activity in cell-
attached patch clamp record-
ings from cells expressing
mGluR1a, GIRK1, Gb1, and Gg2.
(A) Top: a trace from a cell un-
exposed to glutamate, which
shows steady activity of GIRK1.
Bottom: a trace from a cell ex-
posed to glutamate at the time
indicated by the arrow, showing
inhibition of channel activity.
The time period during which
glutamate was added to the
bath is blanked out. (B) Gluta-
mate reduces open probability
(Po) in cells exposed to gluta-
mate. Filled bars, Po in cells ex-
posed to glutamate (n 5 5).
Empty bars, Po in cells unex-
posed to glutamate (n 5 5). Po
was averaged over periods of 3
min. The abscissa shows time
after the start of the record.
Glutamate was added at t 5 3
min (arrow).485 Sharon et al.
rent-voltage relationship it exhibited. The agonist-
induced current rapidly inactivated, leaving a steady
current of around half the peak amplitude. This “inac-
tivation” was much faster than the basal GIRK desensiti-
zation or the desensitization of mGluR2-mediated re-
sponses of comparable amplitudes and possibly reflected
a PKC-dependent inhibition of the GIRK activity.
The second observation associated with high mGluR1a
concentrations (in oocytes injected with GIRK1 and 5 ng
mGluR1a RNAs) was a reduction in basal GIRK activity
(IhK) without the addition of the agonist. This effect
was donor-dependent: in two batches the average IhK
was 41.8 6 16.5% of the average IhK in cells expressing
GIRK1 alone, without the receptor (Student’s t test,
P  , 0.01; n 5 6 cells expressing GIRK1 alone, n 5 11
cells expressing mGluR1a and GIRK1). The third batch
showed no significant difference between the groups
(n 5 3 cells expressing GIRK1 alone, n 5 4 cells ex-
pressing mGluR1a and GIRK1). In the fourth batch
Ba21 was not applied in the hK solution, and therefore
it was impossible to distinguish the basal GIRK1 activity
from the endogenous inward-rectifying current (In).
However, the total inward-rectifying current in hK
(IhK  1 I n) was itself markedly reduced in mGluR1a-
expressing cells (n 5 3): 32.2 6 9.7% of the average to-
tal inward-rectifying current in hK in cells expressing
GIRK1 alone (n 5 5). The inhibition of basal channel
activity at high levels of receptor expression could be
Figure 5. mGluR1a-induced in-
hibition of GIRK is blocked by
PKC inhibitors and mimicked
by PMA. Oocytes expressing
mGluR1a (30 or 50 pg/oocyte),
GIRK1 and GIRK2 (250 or 500
pg/oocyte) were injected with
EGTA before recording (except
in F). In A, B, D and E, the treat-
ments are presented as follows:
empty bars, no treatment (vehicle
only); shaded bars, BIS; black bars,
staurosporine. (A) Staurospo-
rine and BIS do not significantly
alter the amplitude of IhK. Sum-
mary of two oocyte batches, n 5
8 for each treatment. In each
oocyte, IhK was normalized to
the average IhK amplitude in un-
treated cells of the same oocyte
batch. (B) Staurosporine and
BIS attenuate the basal desensi-
tization of IhK. Same oocytes as
in A. In each oocyte, the extent
of desensitization was calcu-
lated as [1 2 (IhK at the end of
the 8 min exposure to hK)/
(peak IhK)] 3 100%. (C) Gluta-
mate (trace denoted: 1 gluta-
mate) fails to cause inhibition of
GIRK in a representative cell
treated with staurosporine; the
activation of GIRK remains un-
impaired. For comparison, a re-
cord is shown from an oocyte
(from the same donor) treated
with staurosporine but not ex-
posed to glutamate (no gluta-
mate). (D) The mGluR1a-induced
inhibition of IhK is suppressed by
BIS and staurosporine: a sum-
mary of two experiments. Same
oocytes batches as in A and B.
The extent of IhK inhibition was
calculated as explained in Fig. 3 C. (E) mGluR1a-induced GIRK activation is not significantly changed by BIS and staurosporine. (F)
PMA inhibits the basal GIRK current. Oocytes were incubated in ND96 as usual and, at t 5 0, exposed either to the normal hK solution
(no PMA; n 5 5) or to hK containing 10 nM PMA (1 PMA; n 5 5). Records averaged from all oocytes in each group are shown.486 Positive and Negative Coupling of mGluRs to GIRK
due to enough receptor molecules being spontane-
ously active without agonist, thereby continually activat-
ing the inhibitory cascade at a significant level (cf.
Prezeau et al., 1996).
discussion
Positive and Negative Coupling of mGluRs to GIRK
This study shows that mGluRs couple to the GIRK chan-
nel in Xenopus oocytes. The Gi/Go-coupled mGluRs acti-
vate the channel in a PTX-sensitive manner, while the
Gq-coupled mGluRs inhibit the channel, an effect
which appears to be mediated by protein kinase C–cata-
lyzed phosphorylation.
The fact that mGluR2, mGluR3, mGluR4, mGluR6,
and mGluR7 activate the channel is consistent with pre-
vious findings of the channel being activated by Gi-cou-
pled receptors. These data confirm and extend similar
findings of Saugstad et al. (1996) published while this
manuscript was under revision toward resubmission.
Coupling to GIRK1 may provide a simple and conve-
nient functional assay for studying the Gi-coupled
mGluRs in the oocyte.
A somewhat unexpected observation was the inhibi-
tion of basal and ACh-evoked (via a coexpressed m2 re-
ceptor) GIRK activity by the PLC-coupled mGluR1 or
mGluR5. The inhibitory effect of mGluR1 was observed
with GIRK channels of GIRK1/GIRK2 and (presum-
ably) GIRK1/GIRK5 composition. We also found that
two additional PLC-coupled receptors, the serotoner-
gic 5HT2C and the muscarinic m1 receptors, inhibit
GIRK (data not shown). Like the mGluR1a-evoked
Ca21-dependent Cl2 current, the inhibition of GIRK by
activation of mGluR1a showed little PTX sensitivity, sug-
gesting that both phenomena are mediated primarily by
a PTX-insensitive G protein, probably of the Gq family.
The fact that some brain regions are common to
both GIRK1 and mGluR expression makes it possible
that the modulation of GIRK by mGluRs is an in vivo
occurring phenomenon. Prominent among these re-
gions, in regard to levels of expression and variety of
mGluRs expressed, are the cerebral cortex, hippocam-
pus (both Ammon’s horn and granule cells in the den-
tate gyrus) and olfactory system (Masu et al., 1991;
Tanabe et al., 1992; Abe et al., 1992; Tanabe et al.,
1993; Okamato et al., 1994; Romano et al., 1995; Neki
et al., 1996). Coupling of mGluRs to GIRK may be a
means by which glutamate modulates the excitability of
its target cell and could thus be involved in plasticity-
related phenomena.
PKC Mediates the Inhibitory Effect of mGluR1a
Cell-attached patch-clamp recordings in which gluta-
mate applied outside the pipette caused an inhibition
of GIRK activity suggest that a second messenger medi-
ates the effect of mGluR1a. The delay between applica-
tion of glutamate and the onset of inhibition was ,1
min in the whole-cell recordings (Fig. 2), as compared
with z3 min in cell-attached patches (Fig. 4), in which
the second messenger presumably had to diffuse to the
vicinity of the channel sealed within the pipette. The slow-
ness of diffusion indicates that it may occur in the plane
of the membrane and/or is carried by a molecule
whose diffusion is restricted (e.g., diacylglycerol), be-
cause small, water-soluble second messenger molecules
such as Ca21, cAMP or inositol trisphosphate evoke
membrane responses within seconds when injected
into  Xenopus oocytes (see Dascal, 1987).
Normally, activation of mGluR1a elicited a large
Ca21-activated Cl2 current evoked by the IP3-mediated
Ca21 release. Injection of EGTA efficiently suppressed
the transient Cl2 current but did not impair the ability
of mGluR1a to inhibit GIRK currents. Thus, it is un-
likely that the inhibition of GIRK is mediated by Ca21
or by a protein that depends solely on Ca21 level in-
crease for activation (such as calmodulin or Ca21/cal-
modulin-dependent protein kinase).
Involvement of PKC is implicated in the inhibitory ef-
fect of PLC-coupled mGluRs by two lines of evidence:
(a) This effect is suppressed by two potent blockers,
staurosporine (a wide-specificity blocker) and BIS (a
specific PKC blocker). The fact that calphostin C did
not block the mGluR1a-induced inhibition of GIRK
may be related to an experimental problem, but it may
also indicate the participation of a specific PKC subtype
(see below). (b) The inhibitory action was mimicked by
PMA, a specific PKC activator. PKC-mediated inhibi-
tion of GIRK may be physiologically relevant. The PLC-
coupled neuropeptide, substance P, has been shown to
inhibit a G protein–dependent K1 channel in nucleus
basalis neurons via a PTX-insensitive G protein, and the
involvement of PKC has been proposed (Velimerovic et
al., 1995). There is no evidence thus far whether the
phosphorylated protein is one of the GIRK subunits or
a different protein exerting an effect on the channel
(e.g., Gbg).
It is not clear which PKC subtype mediates the
mGluR1a-induced inhibition, but candidates may be in-
ferred from the available data. The PKC family is di-
vided into three subfamilies (Newton, 1995; Nishizuka,
1995). The involvement of “classical” PKC subtypes (a,
b, and g) is unlikely, because they depend on Ca21 in
their activation (whereas mGluR1a-induced inhibition
of GIRK is not impaired by Ca21 chelation) and are sen-
sitive to calphostin C. The “atypical” PKCs are not acti-
vated by PMA. This leaves one or more of the “new”
PKC subtypes as viable candidates; notably, PKC-m is in-
sensitive to calphostin C (Johannes et al., 1995) and ap-
pears to be a plausible one. It remains to be clarified487 Sharon et al.
whether the mGluR1a inhibition is mediated by this
PKC subtype because it is the most abundant PKC in
the oocyte, or because it specifically affects the GIRK
activation pathway. Interestingly, Shapiro et al. (1996)
have reported recently that activation of a PKC subtype
with an identical pharmacological profile disrupts the
norepinephrine-induced, Gbg-mediated (Herlitze et al.,
1996; Ikeda, 1996) inhibition of a voltage-dependent
Ca21 channel in rat superior cervical ganglion neurons.
It is tempting to speculate that, in both cases, the mech-
anisms of PKC action may be similar.
Activation and Inhibition of GIRK Are Mediated by Different 
G Proteins: The Problem of Specificity
The differential effects of PTX demonstrate that most
of the activation of GIRK is mediated by a PTX-sensitive
G protein; in contrast, a major part of the inhibitory ef-
fect of mGluR1a is mediated by a PTX-insensitive G
protein. The coupling of mGluR1a to the inhibitory
process was better than to the activation of GIRK. The
extent of the inhibition of basal or acetylcholine-evoked
GIRK activity was nearly identical (z50% of peak cur-
rent) with either 25, 30, or 50 pg mGluR1a RNA per
oocyte; the large GIRK response in oocytes injected
with 5 ng mGluR1a RNA also rapidly “inactivated” to
z50% of total amplitude. This suggests that the inhibi-
tory, Gq-mediated pathway was activated almost to satu-
ration at the lowest levels of receptor expression em-
ployed in this work. In contrast, activation of GIRK by
mGluR1a was far from maximal with 25–50 pg RNA
(,30% of basal activity) and became comparable to
the activation achieved by the Gi/Go-coupled mGluR2,
i.e., several fold higher than the basal activity, only at
higher levels of receptor expression. Activation of
GIRK by mGluR1a at high expression levels (several
tens of nanograms of receptor RNA were injected per
oocyte) was also reported by Saugstad et al. (1996); this
activation was also highly PTX-sensitive. These data in-
dicate a specific coupling of mGluR1a to a PLC-cou-
pled, PTX-insensitive G protein, most probably of the
Gq class, as expected from its known properties. Cou-
pling to Gi/Go proteins appears to be less efficient and
occurs at high levels of expression of the receptor.
Such promiscuous coupling to G proteins is well docu-
mented for many receptor types, but its physiological
significance remains unclear (see Hedin et al., 1993;
Gudermann et al, 1996). Thus, under physiological
conditions, the main effect of activation of mGluR1a
must be the inhibition of GIRK channels rather than
their activation.
The inhibition of GIRK1 by Gq-coupled receptors bears
upon the problem of specificity of G protein-effector
coupling. Various combinations of Gb and Gg subtypes
activate GIRK almost equipotently (Wickman et al.,
1994; Krapivinsky et al., 1995b), and it is unclear why bg
subunits released from G protein heterotrimers con-
taining the PTX-insensitive Gas or Gaq do not activate
GIRK. One possible mechanism is co-localization of the
relevant Ga-Gbg heterotrimeric complexes with the ef-
fector, in our case GIRK (Simon et al., 1991; Huang et
al., 1995; Neer et al., 1995). Another possibility is an an-
tagonistic or synergistic interaction between Ga and Gbg
subunits, such as found for the various adenylyl cyclase
subtypes (see Inigues-Lluhi et al., 1993; Neer, 1995;
Conklin and Bourne, 1993). Indeed, we have found
that two Ga subunits (Gai1 and Gas) inhibit GIRK in a
membrane-delimited fashion, suggesting that antago-
nistic Ga–Gbg interactions may play a role in determin-
ing the specificity of G protein activation of GIRK
(Schreibmayer et al., 1996). Our present results indi-
cate that, like Gai1 and Gas, proteins of the Gaq family
counteract the activation of GIRK by Gbg, in the latter
case by activating PKC.
There is another open question related to the prob-
lem of specificity of interaction within the receptor–G
protein–GIRK pathway: although both Gaq and Gbg di-
rectly and independently activate PLC-b (Smrcka et al.,
1991; Berstein et al., 1992; Camps et al., 1992; Katz et
al., 1992), evidence has been presented that, in Xenopus
oocytes, PLC is activated mainly by the Gbg moiety of
the Gaq-Gbg heterotrimers (Stehno-Bittel et al., 1995). If
this is so, the question arises as to why Gbg released
from other heterotrimers (e.g., Gi/Go) does not rapidly
inhibit GIRK via the PLC pathway. This question may
be, in fact, relevant to many cell types.
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